Category: Medical
-

STAT+: Pharmalittle: We’re reading about FDA approval for a novel antibiotic, setbacks at Sanofi, and much more
•
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating,…
-

STAT+: Child’s sudden death unnerves a promising area of gene therapy research
•
Gene therapy researchers were converging on a holy grail. A few years ago, researchers at labs and companies…
-

FDA approves first new kind of drug to target gonorrhea in decades
•
A new kind of oral antibiotic to treat gonorrhea has secured Food and Drug Administration approval, the second…
-

STAT+: As superbug fears grow, sales of antibiotics used in food-producing livestock rose dramatically last year
•
Amid fears of superbugs, the sale of medically important antibiotics given to food-producing livestock rose by 16% overall…
-

STAT+: Up and down the ladder: The latest comings and goings
•
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with…
-

STAT+: Europe proposes shortening drug exclusivity period
•
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…
-

STAT+: Pharmalittle: We’re reading about FDA staff fears, a Lilly weight loss drug and much more
•
And so, another working week will soon draw to a close. Not a moment too soon, yes? This…
-

STAT+: FDA staff fear Tracy Beth Høeg will bring bias and instability to embattled drug center
•
WASHINGTON — In 2008, Tracy Beth Høeg, then a resident physician and ultramarathon runner, expressed dismay at vice…
-

STAT+: Small study of Corbus’ CB1-targeting pill shows positive signal
•
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…
-

STAT+: Pharmalittle: We’re reading about Lilly’s new obesity drug, E.U. pharma rules, and much more
•
Top of the morning to you, and a fine one it is. Although quite chilly so far, the…
-

STAT+: Lilly’s next-gen obesity drug delivers major weight loss in Phase 3 trial, but with many discontinuations
•
Eli Lilly’s next-generation obesity drug led to what appears to be the most weight loss seen so far…
-

STAT+: A weakened bill to cut off Chinese biotech firms nears passage, after years of changes
•
WASHINGTON — Congress is poised to pass the Biosecure Act after two years of incremental changes that watered…
-

Myocarditis is a rare but real Covid vaccine side effect. A new study sheds light on what causes it
•
While extensive studies have found Covid-19 vaccines to be safe, effective, and to have saved millions of lives…
-

STAT+: FDA scrutiny of infant RSV shots escalates amid turmoil
•
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…
-

STAT+: Pharmalittle: We’re reading about FDA plans for CAR-T therapies, skinny drug labels, and much more
•
Rise and shine, everyone. The middle of the week is upon us. Have heart, though. You made it…
-

STAT+: Solicitor general urges Supreme Court to review ‘skinny labeling’ and generic drug access
•
In a closely watched case, the U.S. solicitor general has urged the Supreme Court to review a controversy…
Recent Posts
- How March Madness foes can end UConn’s run through bracket
- Tournament bets: 12-over-5 upset pick and the 2-seed with clearest path to Elite Eight
- March Madness: Odds, spreads and totals for every men’s opening round games
- One Battle After Another’s big night: Key takeaways from the 2026 Oscars
- Liberia: LDEA Seizes Drugs Worth L$7.77 Million At Ganta Border – Guinean National Arrested
- Nigeria: Why I Didn’t Panic After Losing Power – Sanusi
- Liberia: Police Declare Jackson’s Home ‘Restricted’ As Crime Scene Reconstruction Continues in Wife’s Death Probe
- Liberia: NCD Launches Historic Nationwide Tour to Assess Needs of Persons With Disabilities
- Liberia: CDC Raises Concern Over Foya Border Tension and Accuses Government of Risking National Peace
- Nigeria: 2027 – Tinubu Directs His Campaign Group to Donate Rice to Nigerians for Ramadan, Lent
- Nigeria: Mining Dispute – Govt Accuses Jupiter Ltd of Smear Campaign Plot During Tinubu’s UK Visit
- Nigeria: Nigerian Govt Denies ‘British Lithium Project’ Seizure, Alleges Smear Campaign Ahead of Tinubu’s UK Visit
Social Media
Advertisement




